1. Home
  2. BOLD vs XBP Comparison

BOLD vs XBP Comparison

Compare BOLD & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • XBP
  • Stock Information
  • Founded
  • BOLD 2018
  • XBP N/A
  • Country
  • BOLD United States
  • XBP United Kingdom
  • Employees
  • BOLD N/A
  • XBP N/A
  • Industry
  • BOLD
  • XBP Business Services
  • Sector
  • BOLD
  • XBP Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • XBP Nasdaq
  • Market Cap
  • BOLD 30.3M
  • XBP 32.2M
  • IPO Year
  • BOLD 2024
  • XBP N/A
  • Fundamental
  • Price
  • BOLD $1.10
  • XBP $0.89
  • Analyst Decision
  • BOLD Buy
  • XBP
  • Analyst Count
  • BOLD 3
  • XBP 0
  • Target Price
  • BOLD $4.00
  • XBP N/A
  • AVG Volume (30 Days)
  • BOLD 362.2K
  • XBP 90.5K
  • Earning Date
  • BOLD 08-11-2025
  • XBP 08-11-2025
  • Dividend Yield
  • BOLD N/A
  • XBP N/A
  • EPS Growth
  • BOLD N/A
  • XBP N/A
  • EPS
  • BOLD N/A
  • XBP N/A
  • Revenue
  • BOLD N/A
  • XBP $142,332,000.00
  • Revenue This Year
  • BOLD N/A
  • XBP N/A
  • Revenue Next Year
  • BOLD N/A
  • XBP N/A
  • P/E Ratio
  • BOLD N/A
  • XBP N/A
  • Revenue Growth
  • BOLD N/A
  • XBP N/A
  • 52 Week Low
  • BOLD $1.00
  • XBP $0.79
  • 52 Week High
  • BOLD $4.72
  • XBP $1.89
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • XBP 38.69
  • Support Level
  • BOLD N/A
  • XBP $0.81
  • Resistance Level
  • BOLD N/A
  • XBP $0.93
  • Average True Range (ATR)
  • BOLD 0.00
  • XBP 0.09
  • MACD
  • BOLD 0.00
  • XBP -0.00
  • Stochastic Oscillator
  • BOLD 0.00
  • XBP 24.80

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About XBP XBP Europe Holdings Inc.

XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology, focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.

Share on Social Networks: